Cassava Sciences (MEX:SAVA) Total Liabilities : MXN1,279.92 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Cassava Sciences Total Liabilities?

Cassava Sciences's Total Liabilities for the quarter that ended in Mar. 2024 was MXN1,279.92 Mil.

Cassava Sciences's quarterly Total Liabilities declined from Sep. 2023 (MXN303.33 Mil) to Dec. 2023 (MXN240.95 Mil) but then increased from Dec. 2023 (MXN240.95 Mil) to Mar. 2024 (MXN1,279.92 Mil).

Cassava Sciences's annual Total Liabilities declined from Dec. 2021 (MXN263.95 Mil) to Dec. 2022 (MXN142.22 Mil) but then increased from Dec. 2022 (MXN142.22 Mil) to Dec. 2023 (MXN240.95 Mil).

Cassava Sciences Total Liabilities Historical Data

The historical data trend for Cassava Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences Total Liabilities Chart

Cassava Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

26.16

41.77

263.95

142.22

240.95

Cassava Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															254.26	306.79	303.33	240.95	1,279.92

Cassava Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cassava Sciences's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	240.949	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	240.95

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2574.365	-	2333.416
	=	240.95

Cassava Sciences's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1279.92	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,279.92

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2584.336	-	1304.416
	=	1,279.92

Cassava Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cassava Sciences (MEX:SAVA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (MEX:SAVA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SAVA:USA PX91:Germany

Address

6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731

Website

https://www.cassavasciences.com

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.